The Bundibugyo Ebola virus takes its name from this small town, where it was first discovered in 2007. Now, the species has returned to eastern Congo, halting life on a busy border.
A second American citizen has tested positive for Ebola in the Democratic Republic of the Congo, the CDC announced Friday, this time a logistics worker deployed with the Christian relief organization Samaritan's Purse in the outbreak's epicenter of Ituri province. The patient, who has not been publicly identified, had been working out of Bunia, the […] The post Second American contracts Ebola in Congo while working for Samaritan's Purse appeared first on American Almanac .
A second American citizen has tested positive for Ebola in the Democratic Republic of the Congo, the CDC announced Friday, this time a logistics worker deployed with the Christian relief organization Samaritan's Purse in the outbreak's epicenter of Ituri province. The patient, who has not been publicly identified, had been working out of Bunia, the provincial capital, and was not directly involved in treating Ebola victims. The case marks another grim milestone in a crisis that has now produced 1,926 confirmed infections and 702 deaths, according to DRC health officials. It also raises hard questions about the true scale of an outbreak that the World Health Organization's own emergencies director says may be four times larger than…Open
University of Oxford researchers are recruiting 50 British volunteers to receive injections of an experimental Ebola vaccine, the first designed to fight the rare Bundibugyo strain now tearing through central Africa. The Phase 1 trial, approved by Britain's Medicines and Healthcare Products Regulatory Agency after animal testing, could begin within weeks, the Daily Mail reported. […] The post Oxford scientists prepare to inject UK volunteers with Ebola vaccine as deadly outbreak claims 100 lives per week appeared first on American Almanac .
University of Oxford researchers are recruiting 50 British volunteers to receive injections of an experimental Ebola vaccine, the first designed to fight the rare Bundibugyo strain now tearing through central Africa. The Phase 1 trial, approved by Britain's Medicines and Healthcare Products Regulatory Agency after animal testing, could begin within weeks, the Daily Mail reported . The urgency is hard to overstate. The Centers for Disease Control and Prevention logged 100 fatalities in the first week of July alone. The wider epidemic has now killed approximately 645 people and produced nearly 1,800 confirmed cases, most of them in the Democratic Republic of Congo, where armed conflict has crippled the health-care response. No approved…Open
AI:University of Oxford researchers are recruiting 50 healthy British adults for a Phase 1 clinical trial of an experimental vaccine targeting the Bundibugyo strain of Ebola. This follows regulatory approval from Britain's Medicines and Healthcare Products Regulatory Agency after successful testing on mice and macaques. The outbreak, which has killed hundreds in central Africa, prompted this rapid development to address a lack of existing treatments for this specific strain. While researchers emphasize that safety protocols remain intact despite the accelerated timeline, the move comes as the virus threatens global security through international travel.Open
SCOTUS upholds birthright citizenship, Melat Kiros poised to become the first Gen Z woman elected to Congress after Colorado primary, some World Cup matches will contend with major U.S. heat wave.
Scientists believe that the Bundibugyo virus persists in an animal species, occasionally spilling over into humans. But they have yet to identify the species.
The sisters of Uganda are teachers, health-care advocates and more. Those who are in their twilight of their life need help. Who will come to their aid?
Health workers have warned that the outbreak, already one of the worst in decades, could take as long as a year to contain if infection rates do not flatten.